(Q37870821)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533874%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

review article

1 reference

title

Leishmaniasis: new insights from an old and neglected disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533874%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533874%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Mario Corbellino

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533874%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

L Schifanella

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533874%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

1 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533874%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Microbiology & Infectious Diseases

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533874%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533874%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

109-118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533874%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21533874%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10096-011-1276-0

30 January 2020

exact match

0 references

cites work

Scientometric analysis of the world-wide research efforts concerning Leishmaniasis

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Phylogeny of Leishmania species based on the heat-shock protein 70 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Is it time to revise the nomenclature of Leishmania?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Complexities of assessing the disease burden attributable to leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Estimation of under-reporting of visceral leishmaniasis cases in Bihar, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Annual incidence of visceral leishmaniasis in an endemic area of Bihar, India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Spread of vector-borne diseases and neglect of Leishmaniasis, Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

The northward spread of leishmaniasis in Italy: evidence from retrospective and ongoing studies on the canine reservoir and phlebotomine vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Risk assessment for canine leishmaniasis spreading in the north of Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Asymptomatic Leishmania infantum infection in an area of northwestern Italy (Piedmont region) where such infections are traditionally nonendemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Sandflies and leishmaniasis in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Leishmaniasis in the World Health Organization Eastern Mediterranean Region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Cutaneous leishmaniasis in the Jordanian side of the Jordan Valley: severe under-reporting and consequences on public health management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Control of visceral leishmaniasis in latin america-a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Visceral leishmaniosis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

The relationship between leishmaniasis and AIDS: the second 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Pediatric visceral leishmaniasis in Albania: a retrospective analysis of 1,210 consecutive hospitalized patients (1995-2009)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Leishmaniasis among organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Visceral leishmaniasis in the early post-transplant period after kidney transplantation: clinical features and therapeutic management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Aspects of the association between leishmaniasis and malignant disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Cutaneous leishmaniasis: an increasing threat for travellers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Leishmaniasis, an emerging infection in travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

New world cutaneous leishmaniasis in travellers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Old world leishmaniasis: an emerging infection among deployed US military and civilian workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

'Active chronic visceral leishmaniasis' in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Diffuse cutaneous leishmaniasis associated with the immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Visceral leishmaniasis in a kidney transplant recipient: parasitic interstitial nephritis, a cause of renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Clinical manifestations and classification of Old World cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Unusual manifestations of tegumentary leishmaniasis in AIDS patients from the New World.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and r

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Comparison of PCR assays for diagnosis of cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Viability and burden of Leishmania in extralesional sites during human dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Diagnosis of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Single-dose liposomal amphotericin B for visceral leishmaniasis in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Two doses of a lipid formulation of amphotericin B for the treatment of Mediterranean visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Oral miltefosine for leishmaniasis in immunocompromised patients: compassionate use in 39 patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Miltefosine for new world cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Miltefosine treatment of Leishmania major infection: an observational study involving Dutch military personnel returning from northern Afghanistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Designing and reporting clinical trials on treatments for cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Injectable paromomycin for Visceral leishmaniasis in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Drug combinations for visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Combination therapy for visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Monoclonal antibodies that distinguish between New World species of Leishmania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Visceral leishmaniasis: a threat to immunocompromised patients in non-endemic areas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1276-0

Leishmaniasis and Biologic Therapies for Rheumatologic Diseases

21 January 2018

1 reference

12 December 2020

Cutaneous leishmaniasis

1 reference

12 December 2020

Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.

1 reference

12 December 2020

Relapsing cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab.

1 reference

12 December 2020

Recurrent leishmaniasis in kidney transplant recipients: report of 2 cases and systematic review of the literature.

1 reference

12 December 2020

Visceral leishmaniasis and anti-TNF-alpha therapy: case report and review of the literature.

1 reference

12 December 2020

Leishmaniasis in HIV infection

1 reference

12 December 2020

Is leishmaniasis becoming endemic in Germany?

1 reference

12 December 2020

Leishmaniasis emergence in Europe.

1 reference

12 December 2020

Use of oral miltefosine for cutaneous leishmaniasis in Canadian soldiers returning from Afghanistan

1 reference

12 December 2020

Multifocal cutaneous leishmaniasis: a new clinical presentation of the disease

1 reference

12 December 2020

Treatment of mucosal leishmaniasis in Latin America: systematic review.

1 reference

12 December 2020

Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis

1 reference

12 December 2020

Leishmania and human immunodeficiency virus coinfection: the first 10 years

1 reference

12 December 2020

Is real-time polymerase chain reaction (PCR) more useful than a conventional PCR for the clinical management of leishmaniasis?

1 reference

12 December 2020